Vapotherm inc (VAPO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-13,844

-12,450

-12,765

-12,880

-12,964

-12,877

-9,459

-11,226

-8,906

Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation expense

1,447

1,081

140

712

1,903

135

133

118

116

Depreciation and amortization

1,097

859

812

786

621

606

570

525

466

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-79

-150

Provision for bad debts

101

27

13

51

13

172

91

8

2

Provision for inventories

23

-

-

-

2

-

-

-

-

Loss on disposal of property and equipment

-3

-

-

-

-23

-

-

-

-

Amortization of discount on debt

63

63

63

64

44

28

55

26

14

Change in fair value of warrants

-

-

-

-

-

0

-171

-254

-128

Changes in operating assets and liabilities, net of acquisition:
Accounts receivable

3,875

1,449

-472

703

-847

1,321

-687

-20

-189

Inventories

12

-1,681

-394

-1,208

-1,780

1,170

1,887

-114

-691

Prepaid expenses and other assets

-33

1,746

-130

-201

-197

-568

1,302

-216

-75

Accounts payable

1,310

1,649

24

-481

-1,094

1,232

-1,678

1,939

-597

Contract liabilities

38

89

-15

-38

22

13

-5

-11

18

Accrued expenses and other current liabilities

2,894

373

1,057

1,969

-1,225

-13

1,378

-1

-2,570

Net cash used in operating activities

-10,722

-11,132

-9,644

-9,055

-9,831

-11,422

-11,511

-6,605

-10,480

Cash flows from investing activities
Purchases of property and equipment

1,558

1,615

968

1,036

1,128

1,183

1,529

1,223

1,245

Acquisition of business, net of cash acquired

-

0

0

0

1,560

-

-

-

-

Net cash used in investing activities

-1,558

-1,615

-968

-1,036

-2,688

-1,183

-1,529

-1,223

-1,245

Cash flows from financing activities
Short-term line of credit

995

576

-253

-844

837

-

-

-

-

Proceeds from exercise of stock options

40

-

-

-

-

-

-

-

-

Proceeds on loans

-

0

0

0

10,500

-

-

-

-

Debt issuance costs

-

-293

0

0

322

-

-

750

1

Proceeds from exercise of stock options and purchase of restricted stock

-

-

-

-

-

214

-167

99

393

Net cash provided by financing activities

1,035

849

48,092

-507

11,015

57,575

20,607

-1,714

392

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-17

-

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

-11,262

-11,867

37,467

-10,611

-1,504

44,970

7,567

-9,542

-11,333

Supplemental disclosures of cash flow information
Interest paid during the period

1,202

1,230

1,273

1,351

939

993

862

597

576

Property and equipment purchases in accounts payable and accrued expenses

36

-87

107

73

42

-451

440

-27

59

Issuance of warrants in conjunction with debt draw down

-

0

0

0

293

-

-

-

-